The Protein A Resin industry is expected to grow over the forecast period due to increasing demand for protein-based therapeutics, rising investments in healthcare and pharmaceuticals, and technological advancements. Additionally, the growing use of protein A resins for the purification of immunoglobulin-based therapeutics, monoclonal antibodies, and recombinant proteins, is expected to fuel the growth of the industry. Furthermore, the emergence of continuous chromatography is expected to offer opportunities for the industry. However, the high cost of purification processes is expected to restrain the growth of the industry.

Protein A Resin market in terms of revenue was estimated to be worth $1.1 Billion in 2020 and is poised to reach $1.9 billion by 2025, growing at a CAGR of 11.4% from 2022 to 2027 according to a latest report published by MarketsandMarkets™. The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R&D spending are expected to drive the growth of this market during the forecast period. However, the high cost of resins is expected to limit the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962